Search clinical trials for: levetiracetam

Total 259 results

University of California, San Francisco
UCB Pharma

Completed

Levetiracetam for Treatment of Pain Associated With Fibromyalgia

Fibromyalgia

United States
Stephanie Merhar, MD

Terminated

Efficacy of Keppra for Neonatal Seizures

Neonatal Seizures

United States
Duke University
UCB Pharma

Terminated

Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
UCB Japan Co. Ltd.

Completed

Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males

Healthy Volunteers

Japan
UCB Japan Co. Ltd.

Completed

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Epilepsy | Partial Onset Seizures

Japan
Johannes Gutenberg University Mainz
UCB Pharma GmbH

Completed

Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs (STEP-ONE)

Focal Epilepsy

Germany
UCB Pharma

Completed

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

Epilepsy, Partial

United States, France, United Kingdom, Germany, Belgium, Mexico, Poland, India, Romania, South Africa, Canada, Brazil, Russian Federation, Czech Republic, Hungary, Italy
SK Life Science, Inc.

Terminated

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Epilepsy | Seizures
Massachusetts General Hospital
UCB Pharma

Withdrawn

Seizure Therapy With Intravenous Levetiracetam and Lorazepam (STILL)

Seizures
UCB Pharma

Completed

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Human Volunteers

China
UCB Pharma

Completed

A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

Human Volunteers

China
Rennes University Hospital
UCB Pharma

Terminated

Prevention of Post-traumatic Seizures With Levetiracetam (TRACK)

Epilepsy, Post-Traumatic

France
UCB Pharma

Completed

Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.

Epilepsy
UCB Pharma

Completed

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Epilepsy

United States
UCB Pharma

Completed

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Epilepsy

Spain
Northwestern University
National Cancer Institute (NCI)

Withdrawn

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Seizure
UCB Pharma

Completed

Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)

Healthy

United Kingdom
Philipps University Marburg Medical Center
UCB Pharma GmbH

Completed

Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy

Epilepsy

Germany
The Epilepsy Study Consortium
GlaxoSmithKline; The Epilepsy Research Foundation

Completed

Photosensitivity Proof of Concept Trial

Photosensitive Epilepsy

United States
Lindner Center of HOPE
UCB Pharma; University of Cincinnati

Completed

Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks

Panic Disorder

United States
UCB Pharma

Completed

Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
Harvey S. Singer
UCB Pharma

Completed

Comparison of Keppra and Clonidine in the Treatment of Tics

Tourette Syndrome | Tic Disorders

United States
UCB Pharma

Completed

Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Epilepsy

France, United States, Belgium, Mexico, Turkey, Germany
Thomas Jefferson University
UCB Pharma

Completed

A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches

Migraine

United States
University of Texas Southwestern Medical Center
UCB Pharma

Completed

Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study

Memory Loss Associated With Corticosteroid Use | Manic State Associated With Corticosteroid Use

United States
The Cleveland Clinic
UCB Pharma

Completed

A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy

Epilepsy | Seizures | Childhood Absence Epilepsy

United States
Rikshospitalet University Hospital
GlaxoSmithKline

Completed

Study of Hormonal Sideeffects in Patients Taking Levetiracetam, Carbamazepine or Lamotrigine for Epilepsy

Epilepsy

Norway
Charite University, Berlin, Germany
UCB Pharma

Completed

Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients (Keppra-2)

Alcohol Dependence | Alcoholic Relapse

Germany
University College, London
Medical Research Council

Completed

Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke

Hemispatial Neglect | Motor Deficit | Right Hemisphere Stroke

United Kingdom
Children's Hospital Medical Center, Cincinnati

Completed

Pharmacokinetics of Levetiracetam (Keppra) in Neonates

Epilepsy | Seizures

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.

Healthy

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

Healthy

United States
Charite University, Berlin, Germany

Completed

Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome

Alcohol Withdrawal Syndrome

Germany
Odense University Hospital

Completed

Levetiracetam in Central Pain in Multiple Sclerosis(MS)

Multiple Sclerosis

Denmark
Odense University Hospital

Completed

Levetiracetam for Painful Polyneuropathy

Painful Polyneuropathy

Denmark
Oslo University Hospital

Unknown

Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)

Subclinical Sleep-Activated Epileptiform Activity | CSWS

Norway
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Non-Fasting Conditions

Healthy

United States
Danish Pain Research Center
UCB Nordic A/S

Completed

Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury

Pain | Injuries, Spinal Cord

Denmark
University Hospital Tuebingen

Completed

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

Epilepsy | Primary Brain Tumor

Germany
Technische Universität Dresden
UCB Pharma GmbH

Completed

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease (LeLeDys)

Parkinson's Disease

Germany
Tri-Service General Hospital

Completed

A Bioequivalence Study of Levetiracetam Versus Keppra

Healthy
Southern California Institute for Research and...

Completed

Efficacy of Levetiracetam in Essential Tremor

Essential Tremor

United States
Johns Hopkins University
UCB Pharma

Completed

Levetiracetam for Benign Rolandic Epilepsy

Epilepsy

United States
Ludwig-Maximilians - University of Munich

Terminated

HEAD-Study Optimizing the Treatment of Children With BECTS (HEAD)

Epilepsy, Rolandic

Germany
Amsterdam UMC, location VUmc
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Medical...

Unknown

Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy

Glioma | Epilepsy

Netherlands
Scienze Neurologiche Ospedaliere

Unknown

Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis (EpIc)

Stroke | Epileptic Seizures

Italy
National Institute of Mental Health (NIMH)

Completed

Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness

Bipolar Disorder

United States

Search clinical trials for: levetiracetam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations